Docetaxel
Docetaxel is a generic chemotherapy drug used to treat certain cancers by inhibiting cell growth. It's administered intravenously as an injection, available in concentrations like 20 mg/mL. Manufactured by Meitheal Pharmaceuticals Inc. under ANDA213768, it's a prescription medication. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | Docetaxel is a generic chemotherapy drug used to treat certain cancers by inhibiting cell growth. It's administered intravenously as an injection, available in concentrations like 20 mg/mL. Manufactured by Meitheal Pharmaceuticals Inc. under ANDA213768, it's a prescription medication. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Docetaxel", "mediaType": "text/html", "description": " Access the FDA dataset for Docetaxel — ANDA 209634 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209634" } ] |
| identifier | ANDA209634 |
| issued | 2016-09-16 |
| keyword |
[ "drug-information", "drug-manufacturers", "drug-safety", "medications", "public-health" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Docetaxel |
